Liver cancer screening in a high-risk population in China fails to reduce mortality - 24/08/11
Doi : 10.1016/j.ehbc.2004.05.003
Abstract |
Question |
Does liver cancer screening reduce mortality from the disease in a high-risk Chinese population?
Study design |
Cluster randomised controlled trial.
Main results |
In people at high risk of liver cancer, screening did not significantly reduce the incidence of primary liver cancer or risk of death compared with no screening (see Table 1), despite earlier detection of the disease (see notes).
| ||||||||||||||||||||||||
Authors’ conclusions |
Liver cancer screening in a high-risk population in China does not reduce mortality from the disease.
Le texte complet de cet article est disponible en PDF.Keywords : Liver cancer, Mass screening, Mortality, Randomised controlled trial
Plan
 | Abstracted from: Chen JG, Parkin DM, Chen QG et al. Screening for liver cancer: results of a randomised controlled trial in Qidong, China. J Med Screen 2003; 10: 204–209. |
© 2004
Elsevier Ltd. Tous droits réservés.
Vol 8 - N° 4
P. 221-223 - août 2004 Retour au numéro
Article précédent
- H. pylori eradication does not reduce gastric cancer incidence in a high-risk area of China
- Bor-Shyang Sheu, Xi-Zhang Lin
- Hormone replacement therapy is not safe for breast cancer survivors
- Rena Vassilopoulou-Sellin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?